Haemonetics Corporation · NYSE:HAE
Maunsell Farris Maryanne received 2,220 Haemonetics Corporation shares as an award (Form 4)
Traded May 15, 2026 · Filed May 19, 2026
On May 15, 2026, Maunsell Farris Maryanne (VP, Chief Accounting Officer) received 2,220 Haemonetics Corporation shares as an award, leaving 6,501 shares. Filed May 19, 2026 (Form 4).
- Awarded
- 2,220 shares
- Holding after
- 6,501 shares
- Trading plan
- No
- Role
- VP, Chief Accounting Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 15, 2026 | Common Stock | Shares withheld for tax | 197 | US$56.29 | 4,281 | Direct |
| May 15, 2026 | Common Stock | Award | 2,220 | 6,501 | Direct |
Source
Related
- Haemonetics Corporation
- Maunsell Farris Maryanne
- Haemonetics Corporation shareholders
- Form 4 · Maunsell Farris Maryanne · Jun 8, 2026
- Schedule 13G/A · AQR Capital Management LLC · Aug 12, 2026
- Form 4 · Abernathy Robert E · Jul 28, 2026
- Form 4 · Madaus Martin D · Jul 28, 2026
- Form 4 · Zane Ellen M · Jul 28, 2026
- Form 4 · Pomeroy Claire · Jul 28, 2026